Immunology Research
To learn more about immune system conditions and ongoing clinical trials in this area, visit our Immunology Research page.
Learn MoreThe main purpose of this study is to evaluate the efficacy and safety of lebrikizumab with/without Topical Corticosteroid Treatment in Participants with Moderate-to-Severe Atopic Dermatitis.
Have chronic AD that has been present for ≥1 year before the screening period or have chronic eczema and meet the AAD criteria
Have moderate-to-severe AD, including all of the following at the baseline: EASI score ≥16,IGA score ≥3 (scale of 0 to 4) , ≥10% BSA of AD involvement
Have a history of anaphylaxis or uncontrolled chronic disease that might require bursts of oral corticosteroids
Have a current or recent acute, active infection. For at least 30 days before screening and up to the randomization, participants must have no symptoms or signs of confirmed or suspected infection and must have completed any appropriate anti-infective treatment
To learn more about immune system conditions and ongoing clinical trials in this area, visit our Immunology Research page.
Learn MoreTo learn more about pediatric clinical trials, and access resources for children, young people, and caregivers, visit our Pediatric Research page.
Learn MoreA clinical trial helps us learn if a new potential medicine or treatment works and how it works. Clinical trials are also called clinical research studies. To learn more about what to expect when taking part in a clinical trial, visit our Clinical Trial Information page.